Medico Intercontinental Intrinsic Value
MIL Valuation Methods Summary
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| Book Value Method | asset | ₹49.00 | ₹44.10 - ₹53.90 | +25.0% | Book Value/Share: ₹49.00, P/B: 1.0x |
| Revenue Multiple Method | revenue | ₹67.20 | ₹60.48 - ₹73.92 | +71.5% | Revenue/Share: ₹84.00, P/S: 0.8x |
| Simple DCF (5Y) | dcf | ₹55.70 | ₹44.56 - ₹66.84 | +42.1% | CF Growth: 5.0%, Discount: 15% |
Want to compare with current market value? Check MIL share price latest .
Valuation Comparison Chart
MIL Intrinsic Value Analysis
What is the intrinsic value of MIL?
Based on our comprehensive analysis using 3 different valuation methods, the estimated intrinsic value of Medico Intercontinental (MIL) is ₹55.70 (median value). With the current market price of ₹39.19, this represents a +42.1% variance from our estimated fair value.
The valuation range spans from ₹49.00 to ₹67.20, indicating ₹49.00 - ₹67.20.
Is MIL undervalued or overvalued?
Based on our multi-method analysis, Medico Intercontinental (MIL) appears to be trading below calculated value by approximately 42.1%.
Financial Health Analysis
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Current Ratio | 4.07 | Industry Standard: 2.0+ | Above 2.0 | Measures short-term liquidity capacity |
| Debt to Equity Ratio | 1.55 | Industry Standard: <0.5 | Above 1.0 | Indicates financial leverage level |
| Return on Equity | -40.8% | Industry Standard: 15%+ | Below 10% | Measures shareholder return efficiency |
| Operating Margin | -4.0% | Industry Standard: 20%+ | Below 10% | Indicates operational efficiency level |
| Asset Turnover Ratio | 1.11x | Industry Standard: 1.0x+ | Above 1.0x | Measures asset utilization efficiency |
Related Pages for Medico Intercontinental
Additional stock information and data for MIL
Cash Flow Quality Analysis
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2025 | ₹-7 Cr | ₹-8 Cr | Negative Cash Flow | 3/10 |
| March 2024 | ₹6 Cr | ₹2 Cr | Positive Free Cash Flow | 7/10 |
| March 2023 | ₹-10 Cr | ₹-13 Cr | Negative Cash Flow | 3/10 |
| March 2022 | ₹4 Cr | ₹4 Cr | Positive Free Cash Flow | 8/10 |
| March 2021 | ₹6 Cr | ₹6 Cr | Positive Free Cash Flow | 8/10 |